Sept 2022, automated full molecular cervical cancer screening presented at the ESCV
At the ESCV 2022 conference in Manchester, Self-screen’s Senior Scientific Officer Bart Hesselink demonstrated the automated full molecular cervical cancer screening.
The NeuMoDx HPV Test strip with PreCursor/M+/QIAsure Methylation Test is clinically validated to screen women at risk and identify those in immediate need of treatment.
